{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T07:30:35Z","timestamp":1762673435090},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1990,2,1]],"date-time":"1990-02-01T00:00:00Z","timestamp":633830400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mycopathologia"],"published-print":{"date-parts":[[1990,2]]},"DOI":"10.1007\/bf00436788","type":"journal-article","created":{"date-parts":[[2004,11,11]],"date-time":"2004-11-11T14:07:36Z","timestamp":1100182056000},"page":"75-87","source":"Crossref","is-referenced-by-count":24,"title":["New antifungal agents for the systemic mycoses"],"prefix":"10.1007","volume":"109","author":[{"given":"Samuel M.","family":"Ringel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/0002-9343(87)90123-9","volume":"82","author":"TR Best","year":"1987","unstructured":"Best TR, Jenkins JK, Murphy FY, Nicks SA, Bussel KL, Vesely DL. Persistent adrenal insufficiency secondary to low-dose ketoconazole therapy. Amer J Med 1987; 82: 676?80.","journal-title":"Amer J Med"},{"issue":"Suppl 1","key":"CR2","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1093\/clinids\/9.Supplement_1.S57","volume":"9","author":"D Borelli","year":"1987","unstructured":"Borelli D. A clinical trial of itraconazole in the treatment of deep mycoses of leishmaniasis. Rev Inf Dis 1987; 9(Suppl 1): S57?63.","journal-title":"Rev Inf Dis"},{"key":"CR3","first-page":"141","volume-title":"Recent trends in the discovery, development and evaluation of antifungal agents","author":"FT Boyle","year":"1987","unstructured":"Boyle FT, Ryley JF, Wilson RG. In vitro-in vivo correlations with azole antifungals. In: Fromtling RA (ed.) Recent trends in the discovery, development and evaluation of antifungal agents. JR Prous Publishers, Barcelona 1987; 141?9."},{"key":"CR4","first-page":"141","volume-title":"Recent trends in the discovery, development and evaluation of antifungal agents","author":"KW Brammer","year":"1987","unstructured":"Brammer KW, Tarbit MH. A review of the pharmacokinetics of fluconazole (UK-49, 858) in laboratory animals and man. In: Fromtling RA (ed.) Recent trends in the discovery, development and evaluation of antifungal agents. JR Prous Publishers, Barcelona 1987; 141?9."},{"key":"CR5","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1128\/AAC.21.1.151","volume":"21","author":"C Brass","year":"1982","unstructured":"Brass C, Galgiani JN, Blaschke TF, Defelice R, O'Reilly RA, Stevens DA. Disposition of ketoconazole, an oral antifungal, in humans. Antimicrob Agents Chemother 1982; 21: 151?8.","journal-title":"Antimicrob Agents Chemother"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/clpt.1985.42","volume":"37","author":"MW Brown","year":"1985","unstructured":"Brown MW, Maldonado AL, Meredith CG, Speeg Jr KV. Effect of ketoconazole on hepatic oxidative drug metabolism. Clin Pharmacol Ther 1985; 37: 290?7.","journal-title":"Clin Pharmacol Ther"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.25.1.1","volume":"25","author":"TK Daneshmend","year":"1984","unstructured":"Daneshmend TK, Warnock DW, Ene MD, Johnson EM, Potten MR, Richardson MD, Williamson PJ. Influence of food on the pharmacokinetics of ketoconazole. Antimicrob Agents Chemother 1984; 25: 1?3.","journal-title":"Antimicrob Agents Chemother"},{"key":"CR8","first-page":"251","volume-title":"Recent trends in the discovery, development and evaluation of antifungal agents","author":"R Coster De","year":"1987","unstructured":"De Coster R, Beerens D, Haelterman C, Doolaege R. Effects of itraconazole on the pituitary-testicular-adrenal axis: An overview of preclinical and clinical studies. In: Fromtling RA (ed.) Recent trends in the discovery, development and evaluation of antifungal agents. JR Prous publishers, Barcelona 1987; 251?61."},{"key":"CR9","first-page":"609","volume-title":"Goodman and Gilman's The pharmacological basis of therapeutics","author":"WW Douglas","year":"1980","unstructured":"Douglas WW. Histamine and 5-hydroxytryptamine (serotonin) and their antagonists. In: Goodman Gilman A, Goodman LS, Gilman A (eds.) Goodman and Gilman's The pharmacological basis of therapeutics. Sixth Ed. Macmillan Publishers, New York1980; 609?46.","edition":"Sixth Ed"},{"issue":"Suppl 1","key":"CR10","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1093\/clinids\/9.Supplement_1.S71","volume":"9","author":"B Dupont","year":"1987","unstructured":"Dupont B, Drouhet E. Early experience with itraconazole in vitro and in patients: pharmacokinetic studies and clinical results. Rev Inf Dis 1987; 9(Suppl 1): S71?6.","journal-title":"Rev Inf Dis"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/02681218880000081","volume":"26","author":"B Dupont","year":"1988","unstructured":"Dupont B, Drouhet E. Fluconazole in the management of oropharyngeal candidosis in a predominantly HIV antibody-positive group of patients. J Med Vet Mycol 1988; 26: 67?71.","journal-title":"J Med Vet Mycol"},{"key":"CR12","unstructured":"Espinel-Ingroff A, Shadomy S, White S. Correlation of 10- and 20? g experimental diffusion LY121019 disks with agar dilution MICs against isolates of Candida spp. 88th Annual Mtg Amer Soc Microbiol (May 8?13, Miami Beach) 1988; Abst F84."},{"key":"CR13","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1128\/AAC.31.1.11","volume":"31","author":"V Fainstein","year":"1987","unstructured":"Fainstein V, Bodey GP, Elting L, Maksymiuk A, Keating M, McCredie KB. Amphotericin B or ketoconazole therapy of fungal infections in neutropenic cancer patients. Antimicrob Agents Chemother 1987; 31: 11?5.","journal-title":"Antimicrob Agents Chemother"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1128\/CMR.1.2.187","volume":"1","author":"RA Fromtling","year":"1988","unstructured":"Fromtling RA. Overview of medically important antifungal azole derivatives. Clin Microbiol Rev 1988; 1: 187?217.","journal-title":"Clin Microbiol Rev"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1128\/AAC.31.12.1867","volume":"31","author":"J Galgiani","year":"1987","unstructured":"Galgiani J. Antifungal susceptibility tests. Antimicrob Agents Chemother 1987; 31: 1867?70.","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 1","key":"CR16","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1093\/clinids\/9.Supplement_1.S77","volume":"9","author":"A Ganer","year":"1987","unstructured":"Ganer A, Arathoon E, Stevens DA. Initial experience in therapy for prospective mycoses with itraconazole, the first clinically studied triazole. Rev Inf Dis 1987; 9(Suppl 1): S77?86.","journal-title":"Rev Inf Dis"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/clpt.1986.114","volume":"39","author":"AM Glynn","year":"1986","unstructured":"Glynn AM, Slaughter RL, Brass C, D'Ambrosio R, Jusko WJ. Effects of ketoconazole on methylprednisolone pharmacokinetics and cortisol secretion. Clin Pharmacol Ther 1986; 39: 654?9.","journal-title":"Clin Pharmacol Ther"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1128\/AAC.32.5.646","volume":"32","author":"DP Hanger","year":"1988","unstructured":"Hanger DP, Jevons S, Shaw JTB. Fluconazole and testosterone: in vivo and in vitro studies. Antimicrob Agents Chemother 1988; 32: 646?8.","journal-title":"Antimicrob Agents Chemother"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1001\/archinte.1987.00370040092016","volume":"147","author":"RM Hansen","year":"1987","unstructured":"Hansen RM, Reinerio N, Sohnle PG, Abrams RA, Ritch PS, Libnoch JA, Anderson T. ketoconazole in the prevention of candidiasis in patients with cancer. Arch intern Med 1987; 147: 710?712.","journal-title":"Arch intern Med"},{"key":"CR20","first-page":"235","volume":"54","author":"RS Hare","year":"1988","unstructured":"Hare RS, Lobenberg D. Animal models in the search for antifungal agents. ASM News 1988; 54: 235?9.","journal-title":"ASM News"},{"key":"CR21","first-page":"223","volume-title":"Recent trends in the discovery, development and evaluation of antifungal agents","author":"J Heykants","year":"1987","unstructured":"Heykants J, Michiels M, Meuldermans W, Monbaliu J, Lavrijsen K, Van Peer A, Levron JC, Woestenborghs R, Cauwenbergh G. The pharmacokinetics of itraconazole in animals and man: an overview. In: Fromtling RA (ed.) Recent trends in the discovery, development and evaluation of antifungal agents. JR Prous Publishers, Barcelona 1987; 223?49."},{"key":"CR22","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/BF00455667","volume":"101","author":"DR Hospenthal","year":"1988","unstructured":"Hospenthal DR, Rogers AL, Mills GL. Development of amphotericin B liposomes bearing antibody specific to Candida albicans. Mycopathologia 1988; 101: 37?45.","journal-title":"Mycopathologia"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1128\/AAC.30.2.206","volume":"30","author":"Y Huang","year":"1986","unstructured":"Huang Y, Colaizzi JL, Bierman RH, Woestenborghs R, Heykants J. Pharmacokinetics and dose proportionality of ketoconazole in normal volunteers. Antimicrob Agents Chemother 1986; 30: 206?10.","journal-title":"Antimicrob Agents Chemother"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1128\/AAC.32.2.209","volume":"32","author":"CE Hughes","year":"1988","unstructured":"Hughes CE, Bennett RL, Tuna IC, Beggs WH. Activities of fluconazole (UK 49,858) and ketoconazole against ketoconazole-susceptible and -resistant Candida albicans. Antimicrob Agents Chemother 1988; 32: 209?12.","journal-title":"Antimicrob Agents Chemother"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1177\/106002808301700301","volume":"17","author":"AL Hume","year":"1983","unstructured":"Hume AL, Kerkering TM. Ketoconazole (Nizoral, Janssen Pharmaceutica, Inc). Drug Intell Clin Pharm 1983; 17: 169?74.","journal-title":"Drug Intell Clin Pharm"},{"key":"CR26","unstructured":"Janssen Pharmaceutica. Itraconazole basic medical information brochure. August 1987."},{"key":"CR27","unstructured":"Kamyar A, Crandall M, Edwards Jr J. Comparative sensitivities of Candida sp to amphotericin B and LY121019. 88th Annual Mtg Amer Soc Microbiol (May 8?13, Miami Beach) 1988; Abst F85."},{"key":"CR28","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/clpt.1987.179","volume":"42","author":"RJ Kandrotas","year":"1987","unstructured":"Kandrotas RJ, Slaughter RL, Brass C, Jusko WJ. Ketoconazole effects on methylprednisolone disposition and their joint suppression of endogenous cortisol. Clin Pharmacol Ther 1987; 42: 465?70.","journal-title":"Clin Pharmacol Ther"},{"key":"CR29","unstructured":"Kauffman CA, Bradley SF. In vitro susceptibility of Candida species to a new antifungal agent LY121019. 88th Annual Mtg Amer Soc Microbiol (May 8?13, Miami Beach) 1988; Abst F83."},{"key":"CR30","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1128\/AAC.29.4.660","volume":"29","author":"GS Kobayashi","year":"1986","unstructured":"Kobayashi GS, Travis S, Medoff G. Comparison of the in vitro and in vivo activity of the bis-triazole derivative UK 49,858 with that of amphotericin B against Histoplasma capsulatum. Antimicrob Agents Chemother 1986; 29: 660?2.","journal-title":"Antimicrob Agents Chemother"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1128\/AAC.31.12.2005","volume":"31","author":"GS Kobayashi","year":"1987","unstructured":"Kobayashi GS, Travis SJ, Medoff G. Comparison of fluconazole and amphotericin B in treating histoplasmosis in immunosuppressed mice. Antimicrob Agents Chemother 1987; 31: 2005?6.","journal-title":"Antimicrob Agents Chemother"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"533","DOI":"10.7326\/0003-4819-103-4-533","volume":"103","author":"JA Kovacs","year":"1985","unstructured":"Kovacs JA, Kovacs AA, Polis M, Wright WC, Gill VJ, Tuazon CD, Gelmann EP, Lane HC, Longfield R, Overturf G, Macher AM, Fauci AS, Parillo JE, Bennett JE, Masur H. Cryptococcosis in acquired immunodeficiency syndrome. Ann inter Med 1985; 103: 533?8.","journal-title":"Ann inter Med"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1136\/bmj.294.6569.419","volume":"294","author":"G Lake-Bakaar","year":"1987","unstructured":"Lake-Bakaar G, Scheur PJ, Sherlock S. Hepatic reactions associated with ketoconazole in the United Kingdom. Br Med J 1987; 294: 419?22.","journal-title":"Br Med J"},{"issue":"Suppl 1","key":"CR34","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1093\/clinids\/9.Supplement_1.S64","volume":"9","author":"P Lavalle","year":"1987","unstructured":"Lavalle P, Suchil P, De Ovando F, Reynoso S. Itraconazole for deep mycoses: preliminary experience in Mexico. Rev Inf Dis 1987; 9(Suppl 1): S64?70.","journal-title":"Rev Inf Dis"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1378\/chest.73.2.202","volume":"73","author":"HB Levine","year":"1978","unstructured":"Levine HB, Ringel SM, Cobb JM. Therapeutic properties of oral ambruticin (W7783) in experimental pulmonary coccidioidomycosis of mice. Chest 1978; 73: 202?6.","journal-title":"Chest"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1164\/arrd.1978.118.4.715","volume":"118","author":"HB Levine","year":"1978","unstructured":"Levine HB, Cobb JM. Oral therapy for experimental coccidioidomycosis with R41400 (ketoconazole) a new imidazole. Am Rev Respir Dis 1978; 118: 715?21.","journal-title":"Am Rev Respir Dis"},{"key":"CR37","unstructured":"Levine HB. Fluconazole in murine coccidioidomycosis. 26th Intersci Conf Antimicrob Agents Chemother (Sept 28?Oct 1, New Orleans) 1986; Abst 786."},{"key":"CR38","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1128\/AAC.22.1.43","volume":"22","author":"AW Maksymiuk","year":"1982","unstructured":"Maksymiuk AW, Levine HB, Bodney GP. Pharmacokinetics of ketoconazole in patients with neoplastic diseases. Antimicrob Agents Chemother 1982; 22: 43?6.","journal-title":"Antimicrob Agents Chemother"},{"key":"CR39","first-page":"81","volume-title":"Recent trends in the discovery, development and evaluation of antifungal agents","author":"MS Marriott","year":"1987","unstructured":"Marriott MS, Richardson K. The discovery and mode of action of fluconazole. In: Fromtling RA (ed.) Recent trends in the discovery, development and evaluation of antifungal agents, JR Prous Publishers Barcelona 1987; 81?92."},{"key":"CR40","first-page":"169","volume-title":"Recent trends in the discovery, development and evaluation of antifungal agents","author":"F Meunier","year":"1987","unstructured":"Meunier F, Gerain J, Snoeck R, Libotte F, Lambert C, Ceuppens AM. Fluconazole therapy of oropharyngeal candidiasis in cancer patients. In: Fromtling RA (ed.) Recent trends in the discovery, development and evaluation of antifungal agents. JR Prous Publishers, Barcelona 1987; 169?74."},{"key":"CR41","first-page":"157","volume-title":"Recent trends in the discovery development and evaluation of antifungal agents","author":"JM Naeyaert","year":"1987","unstructured":"Naeyaert JM, de Bersaques J, de Cuyper C, Hindryckx Ph, van Landuyt H, Gordts B. Fluconazole (UK-49,858): a novel oral antifungal in the treatment of fungal skin infections. Results of an open study in 43 patients. In: Fromtling RA (ed.) Recent trends in the discovery development and evaluation of antifungal agents. JR Prous Publishers, Barcelona 1987; 157?61."},{"key":"CR42","doi-asserted-by":"crossref","first-page":"13","DOI":"10.7326\/0003-4819-98-1-13","volume":"98","author":"National Institute of Allergy and Infectious Diseases Mycoses Study Group","year":"1983","unstructured":"National Institute of Allergy and Infectious Diseases Mycoses Study Group. Treatment of Systemic mycoses with ketoconazole: Emphasis on toxicity and clinical response in 52 patients. Ann intern Med 1983; 98:13?20.","journal-title":"Ann intern Med"},{"key":"CR43","doi-asserted-by":"crossref","first-page":"861","DOI":"10.7326\/0003-4819-103-6-861","volume":"103","author":"National Institute of Allergy and Infectious Diseases Mycoses Study Group","year":"1985","unstructured":"National Institute of Allergy and Infectious Diseases Mycoses Study Group. Treatment of blastomycosis and histoplasmosis with ketoconazole. Results of a prospective randomized clinical trial. Ann intern Med 1985; 103: 861?72.","journal-title":"Ann intern Med"},{"issue":"Suppl 1","key":"CR44","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1093\/clinids\/9.Supplement_1.S47","volume":"9","author":"R Negroni","year":"1987","unstructured":"Negroni R, Palmieri O, Koren F, Tiraboschi IN, Galimberti RL. Oral treatment of paracoccidioidomycosis and histoplasmosis with itraconazole in humans. Rev Inf Dis 1987; 9(Suppl 1): S47?50.","journal-title":"Rev Inf Dis"},{"key":"CR45","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1128\/AAC.29.4.579","volume":"29","author":"JR Perfect","year":"1986","unstructured":"Perfect JR, Savani DV, Durack DT. Comparison of itraconazole and fluconazole in treatment of cryptococcal meningitis and Candida pyelonephritis in rabbits. Antimicrob Agents Chemother 1986; 29: 579?83.","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 1","key":"CR46","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1093\/clinids\/9.Supplement_1.S87","volume":"9","author":"P Phillips","year":"1987","unstructured":"Phillips P, Fetchick R, Weisman I, Foshee S, Graybill JR. Tolerance to and efficacy of itraconazole in the treatment of systemic mycoses: Preliminary results. Rev Inf Dis 1987; 9(Suppl 1): S87?93.","journal-title":"Rev Inf Dis"},{"key":"CR47","unstructured":"Piper JP, Rinaldi MG, Winn RE. Endemic Candida parapsilosis at a veteran's hospital. 27th Intersci Conf Antimicrob Agents Chemother (Oct 4?7, New York) 1987; Abst 1292."},{"key":"CR48","doi-asserted-by":"crossref","first-page":"370","DOI":"10.7326\/0003-4819-97-3-370","volume":"97","author":"A Pont","year":"1982","unstructured":"Pont A, Williams PL, Loose DS, Feldman D, Reitz RE, Bochra C, Stevens DA. Ketoconazole blocks adrenal steroid synthesis. Ann intern Med 1982; 97: 370?2.","journal-title":"Ann intern Med"},{"key":"CR49","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1001\/archinte.1982.00340250097015","volume":"142","author":"A Pont","year":"1982","unstructured":"Pont A, Williams PL, Azhar S, Reitz RE, Bochra C, Smith ER, Stevens DA. Ketoconazole blocks testosterone synthesis. Arch intern Med 1982; 142: 2137?40.","journal-title":"Arch intern Med"},{"key":"CR50","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1001\/archinte.1984.04400020052007","volume":"144","author":"A Pont","year":"1984","unstructured":"Pont A, Graybill JR, Craven PC, Galgiani JN, Dismukes WE, Reitz RE, Stevens DA. High-dose ketoconazole therapy and adrenal and testicular function in humans. Arch intern Med 1984; 144: 2150?3.","journal-title":"Arch intern Med"},{"key":"CR51","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1080\/02681218680000691","volume":"24","author":"AL Reingold","year":"1986","unstructured":"Reingold AL, Dong Lu X, Plikaytis BD, Ajello L. Systemic mycoses in the United States 1980?1982. J Med Vet Mycol 1986; 24:433?6.","journal-title":"J Med Vet Mycol"},{"key":"CR52","doi-asserted-by":"crossref","first-page":"779","DOI":"10.4049\/jimmunol.113.3.779","volume":"113","author":"R Renoux","year":"1974","unstructured":"Renoux R, Renoux M. Modulation of immune reactivity by phenylimidothiazole salts in mice immunized by sheep red blood cells. J Immunol 1974; 113: 779?90.","journal-title":"J Immunol"},{"issue":"Suppl 1","key":"CR53","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1093\/clinids\/9.Supplement_1.S51","volume":"9","author":"A Restrepo","year":"1987","unstructured":"Restrepo A, Gomez I, Robledo J, Patino MM, Cano LE. Itraconazole in the treatment of paracoccidioidomycosis: A preliminary report. Rev Inf Dis 1987; 9(Suppl 1): S51?6.","journal-title":"Rev Inf Dis"},{"key":"CR54","unstructured":"Riley K, Antoniskis D, Evans S, Larsen RA. AIDS-related histoplasmosis in a non-endemic area. 88th Annual Mtg Amer Soc Microbiol (May 8?13, Miami Beach) 1988; Abst F97."},{"key":"CR55","doi-asserted-by":"crossref","first-page":"371","DOI":"10.7164\/antibiotics.30.371","volume":"30","author":"SM Ringel","year":"1977","unstructured":"Ringel SM, Greenough RC, Roemer S, Connor D, Gutt AL, Blair B, Kanter G, von Strandtmann M. Ambruticin (W7783) a new antifungal antibiotic. J Antibiot 1977; 30: 371?5.","journal-title":"J Antibiot"},{"key":"CR56","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1128\/AAC.13.5.762","volume":"13","author":"SM Ringel","year":"1978","unstructured":"Ringel SM. In vitro and in vivo studies of ambruticin (W7783): new class of antifungal antibiotics. Antimicrob Agents Chemother 1978; 13: 762?9.","journal-title":"Antimicrob Agents Chemother"},{"key":"CR57","first-page":"585","volume-title":"Recent trends in the discovery, development and evaluation of antifungal agents","author":"SM Ringel","year":"1987","unstructured":"Ringel SM. Ambruticin: a unique oral antibiotic. In: Fromtling RA (ed.) Recent trends in the discovery, development and evaluation of antifungal agents. JR Prous Publishers, Barcelona 1987; 585?93."},{"key":"CR58","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1128\/AAC.30.3.418","volume":"30","author":"TE Rogers","year":"1986","unstructured":"Rogers TE, Galgiani JN. Activity of fluconazole (UK 49,858) and ketoconazole against Candida albicans in vitro and in vivo. Antimicrob Agents Chemother 1986; 30: 418?22.","journal-title":"Antimicrob Agents Chemother"},{"key":"CR59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.32.1.1","volume":"32","author":"MS Saag","year":"1988","unstructured":"Saag MS, Dismukes WE. Azole antifungal agents: emphasis on new triazoles. Antimicrob Agents Chemother 1988; 32: 1?8.","journal-title":"Antimicrob Agents Chemother"},{"key":"CR60","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1128\/AAC.31.1.6","volume":"31","author":"DV Savani","year":"1987","unstructured":"Savani DV, Perfect JR, Cobo LM, Durack DT. Penetration of new azole compounds into the eye and efficacy in Candida endophthalmitis. Antimicrob Agents Chemother 1987; 31: 6?10.","journal-title":"Antimicrob Agents Chemother"},{"key":"CR61","first-page":"595","volume-title":"Recent trends in the discovery, development and evaluation of antifungal agents","author":"CL Schaffner","year":"1987","unstructured":"Schaffner CL. Amphotericin B derivatives. In: Fromtling RA (ed.) Recent trends in the discovery, development and evaluation of antifungal agents. JR Prous Publishers, Barcelona 1987; 595?618."},{"key":"CR62","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1128\/AAC.14.1.99","volume":"14","author":"S Shadomy","year":"1978","unstructured":"Shadomy S, Dixon DM, Espinel-Ingroff A, Wagner GE, Yu HP, Shadomy HJ In vitro studies with ambruticin, a new antifungal antibiotic. Antimicrob Agents Chemother 1978; 14: 99?104.","journal-title":"Antimicrob Agents Chemother"},{"key":"CR63","first-page":"125","volume-title":"Recent trends in the discovery, development and evaluation of antifungal agents","author":"JTB Shaw","year":"1987","unstructured":"Shaw JTB, Tarbit MH, Troke PF. Cytochrome P-450 mediated sterol synthesis and metabolism: Differences in sensitivity to fluconazole and ketoconazole. In: Fromtling RA (ed.) Recent trends in the discovery, development and evaluation of antifungal agents. JR Prous Publishers, Barcelona 1987; 125?39."},{"issue":"Suppl 1B","key":"CR64","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/0002-9343(83)90515-6","volume":"74","author":"DA Stevens","year":"1983","unstructured":"Stevens DA, Stiller RL, Williams PL, Sugar AM. Experience with ketoconazole in 3 major manifestations of progressive coccidioidomycosis. Am J Med 1983; 74 (Suppl 1B): 58?69.","journal-title":"Am J Med"},{"key":"CR65","doi-asserted-by":"crossref","first-page":"54","DOI":"10.7326\/0003-4819-104-1-54","volume":"104","author":"A Tavitian","year":"1986","unstructured":"Tavitian A, Kaufman JP, Rosenthal LE. Oral candidiasis as a marker for esophageal candidiasis in the aquired immunodeficiency syndrome. Ann Intern Med 1986; 104: 54?5.","journal-title":"Ann Intern Med"},{"issue":"Suppl 1","key":"CR66","first-page":"S94","volume":"9","author":"G Tricot","year":"1987","unstructured":"Tricot G, Joosten E, Boogaerts MA, Vande Pitte J, Cauwenbergh G. Ketoconazole vs itraconazole for antifungal prophylaxis in patients with severe granulo-cytopenia: preliminary results of two nonrandomized studies. Rev Inf Dis 1987; 9(Suppl 1): S94?9.","journal-title":"Rev Inf Dis"},{"key":"CR67","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1128\/AAC.32.3.369","volume":"32","author":"RM Tucker","year":"1988","unstructured":"Tucker RM, Williams PL, Arathoon EG, Levine BE, Hartstein AI, Hanson LH, Stevens DA. Pharmacokinetics of fluconazole in cerebrospinal fluid and serum in human coccidioidal meningitis. Antimicrob Agents Chemother 1988; 32: 369?73.","journal-title":"Antimicrob Agents Chemother"},{"key":"CR68","first-page":"633","volume-title":"Recent trends in the discovery, development and evaluation of ntifungal agents","author":"JP Utz","year":"1987","unstructured":"Utz JP. Saramycetin. In: Fromtling RA (ed.) Recent trends in the discovery, development and evaluation of ntifungal agents. JR Prous Publishers, Barcelona 1987; 633?41."},{"key":"CR69","first-page":"207","volume-title":"Recent trends in the discovery, development and evaluation of antifungal agents","author":"H Bossche Vanden","year":"1987","unstructured":"Vanden Bossche H. Itraconazole: a selective inhibitor of the cytochrome P-450 dependent ergosterol biosynthesis. In: Fromtling RA (ed.) Recent trends in the discovery, development and evaluation of antifungal agents. JR Prous Publishers, Barcelona 1987; 207?21."},{"key":"CR70","unstructured":"Zeckner DJ, Gordee RS. Susceptibility of Candida species to LY121019, amphotericin B, and azole antifungal agents. 26th Intersci Conf Antimicrob Agents Chemother (Sept 28?Oct 1, New Orleans) 1986; Abst 1273."},{"key":"CR71","doi-asserted-by":"crossref","first-page":"234","DOI":"10.7326\/0003-4819-104-2-234","volume":"104","author":"A Zuger","year":"1986","unstructured":"Zuger A, Louie E, Holzman RS, Simberkoff MS, Rahal JJ. Cryptococcal disease in patients with the acquired immunodeficiency syndrome: Diagnostic features and outcome of treatment. Ann intern Med 1986; 104: 234?40.","journal-title":"Ann intern Med"}],"container-title":["Mycopathologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00436788.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00436788\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00436788","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,30]],"date-time":"2023-04-30T04:37:53Z","timestamp":1682829473000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00436788"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,2]]},"references-count":71,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1990,2]]}},"alternative-id":["BF00436788"],"URL":"https:\/\/doi.org\/10.1007\/bf00436788","relation":{},"ISSN":["0301-486X","1573-0832"],"issn-type":[{"value":"0301-486X","type":"print"},{"value":"1573-0832","type":"electronic"}],"subject":[],"published":{"date-parts":[[1990,2]]}}}